Brind.

UBS upgraded CVS Health stock to a Buy rating, noting that CVS operates through its Aetna subsidiary.

6 reports, 2 independent Updated Oct 15
Gone quiet
Reports
6
Developments
2
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

UBS upgraded CVS Health stock to a Buy rating, noting that CVS operates through its Aetna subsidiary.

Who's involved

What this event is mainly about
AetnaCVS HealthUBS

How it developed

Newest first. Tap a step to see who reported it.
  1. Leerink partners lowered its price target for CVS Health.1 source
  2. UBS upgraded CVS stock to a Buy rating, while CVS operates through its Aetna subsidiary.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • dailypolitical.com
  • Insider MonkeyJefferies Reiterates a Buy Rating on CVS Health (CVS) With a PT of $80 CVS Health Corporation (NYSE:CVS) is one of the top most undervalued low volatility stocks to buy now. In a report released on A
4 more outlets ran the same wire story